Non-Invasive Prenatal Testing (NIPT)-United States Market Status and Trend Report 2013-2023
Report Summary
Non-Invasive Prenatal Testing (NIPT)-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Non-Invasive Prenatal Testing (NIPT) industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Non-Invasive Prenatal Testing (NIPT) 2013-2017, and development forecast 2018-2023
Main market players of Non-Invasive Prenatal Testing (NIPT) in United States, with company and product introduction, position in the Non-Invasive Prenatal Testing (NIPT) market
Market status and development trend of Non-Invasive Prenatal Testing (NIPT) by types and applications
Cost and profit status of Non-Invasive Prenatal Testing (NIPT), and marketing status
Market growth drivers and challenges
The report segments the United States Non-Invasive Prenatal Testing (NIPT) market as:
United States Non-Invasive Prenatal Testing (NIPT) Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Non-Invasive Prenatal Testing (NIPT) Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Ultrasound Detection
Biochemical Screening Tests
Cell-Free Dna In Maternal Plasma Tests
Fetal Cells In Maternal Blood Tests
Other
United States Non-Invasive Prenatal Testing (NIPT) Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Clinics
Research Laboratories
United States Non-Invasive Prenatal Testing (NIPT) Market: Players Segment Analysis (Company and Product introduction, Non-Invasive Prenatal Testing (NIPT) Sales Volume, Revenue, Price and Gross Margin):
GE Healthcare
Koninklijke Philips
BGI Genomics
Illumina
Thermo Fisher Scientific
F. Hoffmann-La Roche
Pacific Biosciences Of California
Perkinelmer
Qiagen
Agilent Technologies
LifeCodexx
Berry Genomics
LifeLabs Genetics
Quest Diagnostics
Safembryo
Laboratory Corporation of America Holdings
Natera
Sequenom
Ariosa Diagnostics
CombiMatrix
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Non-Invasive Prenatal Testing (NIPT)-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Non-Invasive Prenatal Testing (NIPT) industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Non-Invasive Prenatal Testing (NIPT) 2013-2017, and development forecast 2018-2023
Main market players of Non-Invasive Prenatal Testing (NIPT) in United States, with company and product introduction, position in the Non-Invasive Prenatal Testing (NIPT) market
Market status and development trend of Non-Invasive Prenatal Testing (NIPT) by types and applications
Cost and profit status of Non-Invasive Prenatal Testing (NIPT), and marketing status
Market growth drivers and challenges
The report segments the United States Non-Invasive Prenatal Testing (NIPT) market as:
United States Non-Invasive Prenatal Testing (NIPT) Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Non-Invasive Prenatal Testing (NIPT) Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Ultrasound Detection
Biochemical Screening Tests
Cell-Free Dna In Maternal Plasma Tests
Fetal Cells In Maternal Blood Tests
Other
United States Non-Invasive Prenatal Testing (NIPT) Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Clinics
Research Laboratories
United States Non-Invasive Prenatal Testing (NIPT) Market: Players Segment Analysis (Company and Product introduction, Non-Invasive Prenatal Testing (NIPT) Sales Volume, Revenue, Price and Gross Margin):
GE Healthcare
Koninklijke Philips
BGI Genomics
Illumina
Thermo Fisher Scientific
F. Hoffmann-La Roche
Pacific Biosciences Of California
Perkinelmer
Qiagen
Agilent Technologies
LifeCodexx
Berry Genomics
LifeLabs Genetics
Quest Diagnostics
Safembryo
Laboratory Corporation of America Holdings
Natera
Sequenom
Ariosa Diagnostics
CombiMatrix
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF NON-INVASIVE PRENATAL TESTING (NIPT)
1.1 Definition of Non-Invasive Prenatal Testing (NIPT) in This Report
1.2 Commercial Types of Non-Invasive Prenatal Testing (NIPT)
1.2.1 Ultrasound Detection
1.2.2 Biochemical Screening Tests
1.2.3 Cell-Free Dna In Maternal Plasma Tests
1.2.4 Fetal Cells In Maternal Blood Tests
1.2.5 Other
1.3 Downstream Application of Non-Invasive Prenatal Testing (NIPT)
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Research Laboratories
1.4 Development History of Non-Invasive Prenatal Testing (NIPT)
1.5 Market Status and Trend of Non-Invasive Prenatal Testing (NIPT) 2013-2023
1.5.1 United States Non-Invasive Prenatal Testing (NIPT) Market Status and Trend 2013-2023
1.5.2 Regional Non-Invasive Prenatal Testing (NIPT) Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Non-Invasive Prenatal Testing (NIPT) in United States 2013-2017
2.2 Consumption Market of Non-Invasive Prenatal Testing (NIPT) in United States by Regions
2.2.1 Consumption Volume of Non-Invasive Prenatal Testing (NIPT) in United States by Regions
2.2.2 Revenue of Non-Invasive Prenatal Testing (NIPT) in United States by Regions
2.3 Market Analysis of Non-Invasive Prenatal Testing (NIPT) in United States by Regions
2.3.1 Market Analysis of Non-Invasive Prenatal Testing (NIPT) in New England 2013-2017
2.3.2 Market Analysis of Non-Invasive Prenatal Testing (NIPT) in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Non-Invasive Prenatal Testing (NIPT) in The Midwest 2013-2017
2.3.4 Market Analysis of Non-Invasive Prenatal Testing (NIPT) in The West 2013-2017
2.3.5 Market Analysis of Non-Invasive Prenatal Testing (NIPT) in The South 2013-2017
2.3.6 Market Analysis of Non-Invasive Prenatal Testing (NIPT) in Southwest 2013-2017
2.4 Market Development Forecast of Non-Invasive Prenatal Testing (NIPT) in United States 2018-2023
2.4.1 Market Development Forecast of Non-Invasive Prenatal Testing (NIPT) in United States 2018-2023
2.4.2 Market Development Forecast of Non-Invasive Prenatal Testing (NIPT) by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Non-Invasive Prenatal Testing (NIPT) in United States by Types
3.1.2 Revenue of Non-Invasive Prenatal Testing (NIPT) in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Non-Invasive Prenatal Testing (NIPT) in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Non-Invasive Prenatal Testing (NIPT) in United States by Downstream Industry
4.2 Demand Volume of Non-Invasive Prenatal Testing (NIPT) by Downstream Industry in Major Countries
4.2.1 Demand Volume of Non-Invasive Prenatal Testing (NIPT) by Downstream Industry in New England
4.2.2 Demand Volume of Non-Invasive Prenatal Testing (NIPT) by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Non-Invasive Prenatal Testing (NIPT) by Downstream Industry in The Midwest
4.2.4 Demand Volume of Non-Invasive Prenatal Testing (NIPT) by Downstream Industry in The West
4.2.5 Demand Volume of Non-Invasive Prenatal Testing (NIPT) by Downstream Industry in The South
4.2.6 Demand Volume of Non-Invasive Prenatal Testing (NIPT) by Downstream Industry in Southwest
4.3 Market Forecast of Non-Invasive Prenatal Testing (NIPT) in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF NON-INVASIVE PRENATAL TESTING (NIPT)
5.1 United States Economy Situation and Trend Overview
5.2 Non-Invasive Prenatal Testing (NIPT) Downstream Industry Situation and Trend Overview
CHAPTER 6 NON-INVASIVE PRENATAL TESTING (NIPT) MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Non-Invasive Prenatal Testing (NIPT) in United States by Major Players
6.2 Revenue of Non-Invasive Prenatal Testing (NIPT) in United States by Major Players
6.3 Basic Information of Non-Invasive Prenatal Testing (NIPT) by Major Players
6.3.1 Headquarters Location and Established Time of Non-Invasive Prenatal Testing (NIPT) Major Players
6.3.2 Employees and Revenue Level of Non-Invasive Prenatal Testing (NIPT) Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 NON-INVASIVE PRENATAL TESTING (NIPT) MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 GE Healthcare
7.1.1 Company profile
7.1.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.1.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of GE Healthcare
7.2 Koninklijke Philips
7.2.1 Company profile
7.2.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.2.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of Koninklijke Philips
7.3 BGI Genomics
7.3.1 Company profile
7.3.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.3.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of BGI Genomics
7.4 Illumina
7.4.1 Company profile
7.4.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.4.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of Illumina
7.5 Thermo Fisher Scientific
7.5.1 Company profile
7.5.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.5.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific
7.6 F. Hoffmann-La Roche
7.6.1 Company profile
7.6.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.6.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche
7.7 Pacific Biosciences Of California
7.7.1 Company profile
7.7.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.7.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of Pacific Biosciences Of California
7.8 Perkinelmer
7.8.1 Company profile
7.8.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.8.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of Perkinelmer
7.9 Qiagen
7.9.1 Company profile
7.9.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.9.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of Qiagen
7.10 Agilent Technologies
7.10.1 Company profile
7.10.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.10.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of Agilent Technologies
7.11 LifeCodexx
7.11.1 Company profile
7.11.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.11.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of LifeCodexx
7.12 Berry Genomics
7.12.1 Company profile
7.12.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.12.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of Berry Genomics
7.13 LifeLabs Genetics
7.13.1 Company profile
7.13.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.13.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of LifeLabs Genetics
7.14 Quest Diagnostics
7.14.1 Company profile
7.14.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.14.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of Quest Diagnostics
7.15 Safembryo
7.15.1 Company profile
7.15.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.15.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of Safembryo
7.16 Laboratory Corporation of America Holdings
7.17 Natera
7.18 Sequenom
7.19 Ariosa Diagnostics
7.20 CombiMatrix
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NON-INVASIVE PRENATAL TESTING (NIPT)
8.1 Industry Chain of Non-Invasive Prenatal Testing (NIPT)
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF NON-INVASIVE PRENATAL TESTING (NIPT)
9.1 Cost Structure Analysis of Non-Invasive Prenatal Testing (NIPT)
9.2 Raw Materials Cost Analysis of Non-Invasive Prenatal Testing (NIPT)
9.3 Labor Cost Analysis of Non-Invasive Prenatal Testing (NIPT)
9.4 Manufacturing Expenses Analysis of Non-Invasive Prenatal Testing (NIPT)
CHAPTER 10 MARKETING STATUS ANALYSIS OF NON-INVASIVE PRENATAL TESTING (NIPT)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Non-Invasive Prenatal Testing (NIPT) in This Report
1.2 Commercial Types of Non-Invasive Prenatal Testing (NIPT)
1.2.1 Ultrasound Detection
1.2.2 Biochemical Screening Tests
1.2.3 Cell-Free Dna In Maternal Plasma Tests
1.2.4 Fetal Cells In Maternal Blood Tests
1.2.5 Other
1.3 Downstream Application of Non-Invasive Prenatal Testing (NIPT)
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Research Laboratories
1.4 Development History of Non-Invasive Prenatal Testing (NIPT)
1.5 Market Status and Trend of Non-Invasive Prenatal Testing (NIPT) 2013-2023
1.5.1 United States Non-Invasive Prenatal Testing (NIPT) Market Status and Trend 2013-2023
1.5.2 Regional Non-Invasive Prenatal Testing (NIPT) Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Non-Invasive Prenatal Testing (NIPT) in United States 2013-2017
2.2 Consumption Market of Non-Invasive Prenatal Testing (NIPT) in United States by Regions
2.2.1 Consumption Volume of Non-Invasive Prenatal Testing (NIPT) in United States by Regions
2.2.2 Revenue of Non-Invasive Prenatal Testing (NIPT) in United States by Regions
2.3 Market Analysis of Non-Invasive Prenatal Testing (NIPT) in United States by Regions
2.3.1 Market Analysis of Non-Invasive Prenatal Testing (NIPT) in New England 2013-2017
2.3.2 Market Analysis of Non-Invasive Prenatal Testing (NIPT) in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Non-Invasive Prenatal Testing (NIPT) in The Midwest 2013-2017
2.3.4 Market Analysis of Non-Invasive Prenatal Testing (NIPT) in The West 2013-2017
2.3.5 Market Analysis of Non-Invasive Prenatal Testing (NIPT) in The South 2013-2017
2.3.6 Market Analysis of Non-Invasive Prenatal Testing (NIPT) in Southwest 2013-2017
2.4 Market Development Forecast of Non-Invasive Prenatal Testing (NIPT) in United States 2018-2023
2.4.1 Market Development Forecast of Non-Invasive Prenatal Testing (NIPT) in United States 2018-2023
2.4.2 Market Development Forecast of Non-Invasive Prenatal Testing (NIPT) by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Non-Invasive Prenatal Testing (NIPT) in United States by Types
3.1.2 Revenue of Non-Invasive Prenatal Testing (NIPT) in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Non-Invasive Prenatal Testing (NIPT) in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Non-Invasive Prenatal Testing (NIPT) in United States by Downstream Industry
4.2 Demand Volume of Non-Invasive Prenatal Testing (NIPT) by Downstream Industry in Major Countries
4.2.1 Demand Volume of Non-Invasive Prenatal Testing (NIPT) by Downstream Industry in New England
4.2.2 Demand Volume of Non-Invasive Prenatal Testing (NIPT) by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Non-Invasive Prenatal Testing (NIPT) by Downstream Industry in The Midwest
4.2.4 Demand Volume of Non-Invasive Prenatal Testing (NIPT) by Downstream Industry in The West
4.2.5 Demand Volume of Non-Invasive Prenatal Testing (NIPT) by Downstream Industry in The South
4.2.6 Demand Volume of Non-Invasive Prenatal Testing (NIPT) by Downstream Industry in Southwest
4.3 Market Forecast of Non-Invasive Prenatal Testing (NIPT) in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF NON-INVASIVE PRENATAL TESTING (NIPT)
5.1 United States Economy Situation and Trend Overview
5.2 Non-Invasive Prenatal Testing (NIPT) Downstream Industry Situation and Trend Overview
CHAPTER 6 NON-INVASIVE PRENATAL TESTING (NIPT) MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Non-Invasive Prenatal Testing (NIPT) in United States by Major Players
6.2 Revenue of Non-Invasive Prenatal Testing (NIPT) in United States by Major Players
6.3 Basic Information of Non-Invasive Prenatal Testing (NIPT) by Major Players
6.3.1 Headquarters Location and Established Time of Non-Invasive Prenatal Testing (NIPT) Major Players
6.3.2 Employees and Revenue Level of Non-Invasive Prenatal Testing (NIPT) Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 NON-INVASIVE PRENATAL TESTING (NIPT) MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 GE Healthcare
7.1.1 Company profile
7.1.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.1.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of GE Healthcare
7.2 Koninklijke Philips
7.2.1 Company profile
7.2.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.2.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of Koninklijke Philips
7.3 BGI Genomics
7.3.1 Company profile
7.3.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.3.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of BGI Genomics
7.4 Illumina
7.4.1 Company profile
7.4.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.4.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of Illumina
7.5 Thermo Fisher Scientific
7.5.1 Company profile
7.5.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.5.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific
7.6 F. Hoffmann-La Roche
7.6.1 Company profile
7.6.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.6.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche
7.7 Pacific Biosciences Of California
7.7.1 Company profile
7.7.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.7.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of Pacific Biosciences Of California
7.8 Perkinelmer
7.8.1 Company profile
7.8.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.8.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of Perkinelmer
7.9 Qiagen
7.9.1 Company profile
7.9.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.9.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of Qiagen
7.10 Agilent Technologies
7.10.1 Company profile
7.10.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.10.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of Agilent Technologies
7.11 LifeCodexx
7.11.1 Company profile
7.11.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.11.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of LifeCodexx
7.12 Berry Genomics
7.12.1 Company profile
7.12.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.12.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of Berry Genomics
7.13 LifeLabs Genetics
7.13.1 Company profile
7.13.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.13.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of LifeLabs Genetics
7.14 Quest Diagnostics
7.14.1 Company profile
7.14.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.14.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of Quest Diagnostics
7.15 Safembryo
7.15.1 Company profile
7.15.2 Representative Non-Invasive Prenatal Testing (NIPT) Product
7.15.3 Non-Invasive Prenatal Testing (NIPT) Sales, Revenue, Price and Gross Margin of Safembryo
7.16 Laboratory Corporation of America Holdings
7.17 Natera
7.18 Sequenom
7.19 Ariosa Diagnostics
7.20 CombiMatrix
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NON-INVASIVE PRENATAL TESTING (NIPT)
8.1 Industry Chain of Non-Invasive Prenatal Testing (NIPT)
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF NON-INVASIVE PRENATAL TESTING (NIPT)
9.1 Cost Structure Analysis of Non-Invasive Prenatal Testing (NIPT)
9.2 Raw Materials Cost Analysis of Non-Invasive Prenatal Testing (NIPT)
9.3 Labor Cost Analysis of Non-Invasive Prenatal Testing (NIPT)
9.4 Manufacturing Expenses Analysis of Non-Invasive Prenatal Testing (NIPT)
CHAPTER 10 MARKETING STATUS ANALYSIS OF NON-INVASIVE PRENATAL TESTING (NIPT)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
